Scrip
MTP pays $105 million up front for extended telaprevir rights
31 July 2009
Ian Haydock
Please Login to read the full article.
31 July 2009
Ian Haydock
Mitsubishi Tanabe Pharma (MTP) has amended its 2004 agreement with Vertex Pharmaceuticals for the development and commercialisation of Vertex's oral hepatitis C antiviral telaprevir in Japan and other Asian markets.
The Japanese firm will pay $105 million on signing for rights to develop...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
